■ CD8 モノクローナル抗体(品番:65146-1-Ig)

図1. CD8抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 0.5 ug Anti-Human CD8 (65146-1-Ig, Clone: SK1) and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:1000 (green), or 0.5 ug Mouse IgG1 Isotype Control and CoraLite®488-Conjugated AffiniPure Goat Anti-Mouse IgG(H+L) at dilution 1:1000 (black). Samples were not fixed.
■ CD8 モノクローナル抗体(品番:FITC-65146)

図1. CD8抗体とCD3抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 5.00 ul/test APC-anti-human CD3 (APC-65151, Clone: UCHT1) and 5.00 ul/test FITC-anti-human CD8 (FITC-65146, Clone: SK1). Samples were not fixed.
図2. アイソタイプコントロール抗体とCD3抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 5.00 ul/test APC-anti-human CD3 (APC-65151, Clone: UCHT1) and 0.125 ug FITC-mouse IgG1 isotype control. Samples were not fixed.
■ CD8 モノクローナル抗体(品番:PE-65146)

図1. CD8抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 human peripheral blood lymphocytes were surface stained with 0.125 ug PE-anti-human CD8 (PE-65146, clone SK1) (red) or 0.125 ug PE-mouse IgG1 isotype control (blue). Samples were not fixed.
■ CD8 モノクローナル抗体(品番:APC-65146)

図1. CD8抗体とCD3抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with FITC Anti-Human CD3 (FITC-65151, Clone: UCHT1) and 5.00 ul APC Anti-Human CD8 (APC-65146, Clone: SK1). Lymphocytes were gated for analysis. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD3抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with FITC Anti-Human CD3 (FITC-65151, Clone: UCHT1) and APC Mouse IgG1 isotype control antibody. Lymphocytes were gated for analysis. Cells were not fixed.
■ CD8 モノクローナル抗体(品番:CL488-65146)

図1. CD8抗体とCD3抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with APC Anti-Human CD3 (APC-65151, Clone: UCHT1) and 5.00 ul CoraLite®488-conjugated Anti-Human CD8 (CL488-65146, Clone: SK1). Lymphocytes were gated for analysis. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD3抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with APC Anti-Human CD3 (APC-65151, Clone: UCHT1) and CoraLite®488-conjugated Mouse IgG1 isotype control antibody. Lymphocytes were gated for analysis. Cells were not fixed.
■ CD8 モノクローナル抗体(品番:CL647-65146)

図1. CD8抗体とCD3抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with FITC Anti-Human CD3 (FITC-65151, Clone: UCHT1) and 5.00 ul CoraLite®647-conjugated Anti-Human CD8 (CL647-65146, Clone: SK1). Lymphocytes were gated for analysis. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD3抗体を用いた細胞表面マーカー解析
100 ul human peripheral blood were surface stained with FITC Anti-Human CD3 (FITC-65151, Clone: UCHT1) and CoraLite®647-conjugated Mouse IgG1 isotype control antibody. Lymphocytes were gated for analysis. Cells were not fixed.